Insider trading · Q3 2026 · CIK 1850119

Century Therapeutics, Inc. (IPSC) insider trading.

In Q3 2026, insiders at Century Therapeutics, Inc. reported 8 non-derivative transactions on 10 Forms 3, 4 and 5: 0 open-market purchases and 5 sales worth $10K.

Transactions
8
Purchases (P)
0
Sales (S)
5
Net shares, P minus S
-5,308
Insiders
3
Last filed
2026-09-15

Insiders

InsiderRelationshipTransactionsBuysSales
Carr DouglasOfficer · SVP Finance & Operations303
Pfeiffenberger BrentDirector, Officer · President and CEO300
Russotti GregoryOfficer · See Remarks202

Transactions

8 non-derivative rows, newest transaction first. Shares and prices as filed.
DateInsiderCodeSharesPriceOwned afterFiling
2026-09-14Carr DouglasS (D)1,658$1.93502,907Form 4
2026-09-14Russotti GregoryS (D)2,587$1.93509,198Form 4
2026-09-11Pfeiffenberger BrentF (D)13,850$1.943,633,839Form 4
2026-09-08Carr DouglasS (D)254$2.05504,565Form 4
2026-09-08Russotti GregoryS (D)534$2.05511,785Form 4
2026-09-04Pfeiffenberger BrentF (D)463$2.113,633,839Form 4
2026-08-14Pfeiffenberger BrentF (D)31,172$1.923,634,302Form 4
2026-08-03Carr DouglasS (D)275$1.98504,819Form 4

Transaction codes in this quarter

Get IPSC insider transactions through the API

Request with your API key
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1850119&limit=100" \
  -H "Authorization: Bearer $SEC_API_KEY"

Insider trading API guide · IPSC company page · Century Therapeutics, Inc. on SEC.gov

Questions

Are insiders buying or selling Century Therapeutics, Inc. (IPSC)?

In Q3 2026, insiders at Century Therapeutics, Inc. reported 8 non-derivative transactions on 10 Forms 3, 4 and 5: 0 open-market purchases and 5 sales worth $10K. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.

Where do these Century Therapeutics, Inc. insider trades come from?

From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.

Source: SEC Insider Transactions Data Sets, Q3 2026, retrieved 2026-10-27. Footnotes, derivative holdings and amendments are in the linked filings. Not investment advice.

Plain-text version for agents and LLMs: /insider-trading/ipsc.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.